Iron Particles Enhance Visualization of Experimental Gliomas with High-Resolution Sonography

References

1. ↵
   Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994;34:45–60; discussion 60–61

   CrossRefPubMedWeb of Science
2. ↵
   Wirtz CR, Knauth M, Staubert A, et al. Clinical evaluation and follow-up results for intraoperative magnetic resonance imaging in neurosurgery. Neurosurgery 2000;46:1112–1120; discussion 1120–1122

   CrossRefPubMedWeb of Science
3. ↵
   Hammoud MA, Ligon BL, elSouki R, Shi WM, Schomer DF, Sawaya R. Use of intraoperative ultrasound for localizing tumors and determining the extent of resection: a comparative study with magnetic resonance imaging. J Neurosurg 1996;84:737–741

   PubMed
4. ↵
   Le Roux PD, Berger MS, Wang K, Mack LA, Ojemann GA. Low grade gliomas: comparison of intraoperative ultrasound characteristics with preoperative imaging studies. J Neurooncol 1992;13:189–198

   PubMed
5. ↵
   Chacko AG, Kumar NK, Chacko G, Athyal R, Rajshekhar V. Intraoperative ultrasound in determining the extent of resection of parenchymal brain tumours: a comparative study with computed tomography and histopathology. Acta Neurochir (Wien) 2003;145:743–748; discussion 748

   PubMed
6. ↵
   Maurer M, Becker G, Wagner R, et al. Early postoperative transcranial sonography (TCS), CT, and MRI after resection of high grade glioma: evaluation of residual tumour and its influence on prognosis. Acta Neurochir (Wien) 2000;142:1089–1097

   PubMed
7. ↵
   Varallyay P, Nesbit G, Muldoon LL, et al. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR Am J Neuroradiol 2002;23:510–519

   Abstract/FREE Full Text
8. ↵
   Zimmer C, Weissleder R, Poss K, Bogdanova A, Wright SC Jr, Enochs WS. MR imaging of phagocytosis in experimental gliomas. Radiology 1995;197:533–538

   PubMed
9. ↵
   Goldbrunner RH, Wagner S, Roosen K, Tonn JC. Models for assessment of angiogenesis in gliomas. J Neurooncol 2000;50:53–62

   CrossRefPubMed
10. ↵
    Hamm B, Staks T, Taupitz M, et al. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. J Magn Reson Imaging 1994;4:659–668

    PubMed
11. ↵
    Chen F, Ward J, Robinson PJ. MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents. Magn Reson Imaging 1999;17:549–556

    CrossRefPubMed
12. ↵
    Bendszus M, Stoll G. Caught in the act: in vivo mapping of macrophage infiltration in nerve injury by magnetic resonance imaging. J Neurosci 2003;23:10892–10896

    Abstract/FREE Full Text
13. ↵
    Enzmann DR, Wheat R, Marshall WH, et al. Tumors of the central nervous system studied by computed tomography and ultrasound. Radiology 1985;154:393–399

    PubMed
14. ↵
    Knauth M, Wirtz CR, Tronnier VM, Aras N, Kunze S, Sartor K. Intraoperative MR imaging increases the extent of tumor resection in patients with high-grade gliomas. AJNR Am J Neuroradiol 1999;20:1642–1646

    Abstract/FREE Full Text
15. ↵
    Kelly PJ, Earnest F 4th, Kall BA, Goerss SJ, Scheithauer B. Surgical options for patients with deep-seated brain tumors: computer-assisted stereotactic biopsy. Mayo Clin Proc 1985;60:223–229

    PubMed
16. Kelly PJ, Kall BA, Goerss S, Earnest F. Present and future developments of stereotactic technology. Appl Neurophysiol 1985;48:1–6
17. Kelly PJ, Kall BA, Goerss S, Earnest F 4th. Computer-assisted stereotaxic laser resection of intra-axial brain neoplasms. J Neurosurg 1986;64:427–439

    PubMed
18. ↵
    Nimsky C, Ganslandt O, Cerny S, Hastreiter P, Greiner G, Fahlbusch R. Quantification of, visualization of, and compensation for brain shift using intraoperative magnetic resonance imaging. Neurosurgery 2000;47:1070–1079; discussion 1079–1080

    PubMedWeb of Science
19. ↵
    Knauth M, Aras N, Wirtz CR, Dorfler A, Engelhorn T, Sartor K. Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging. AJNR Am J Neuroradiol 1999;20:1547–1553

    Abstract/FREE Full Text
20. ↵
    Dietrich J, Schneider JP, Schulz T, Seifert V, Trantakis C, Kellermann S. Appearance of the resection area of brain tumors in intraoperative MRI imaging. Radiologe 1998;38:935–942

    PubMed
21. ↵
    Knauth M, Egelhof T, Roth SU, Wirtz CR, Sartor K. Monocrystalline iron oxide nanoparticles: possible solution to the problem of surgically induced intracranial contrast enhancement in intraoperative MR imaging. AJNR Am J Neuroradiol 2001;22:99–102

    Abstract/FREE Full Text
22. ↵
    Berg D, Grote C, Rausch WD, et al. Iron accumulation in the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol 1999;25:901–904

    CrossRefPubMedWeb of Science
23. ↵
    Berg D, Roggendorf W, Schroder U, et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002;59:999–1005

    CrossRefPubMedWeb of Science
24. ↵
    Zimmer C, Wright SC Jr, Engelhardt RT, et al. Tumor cell endocytosis imaging facilitates delineation of the glioma-brain interface. Exp Neurol 1997;143:61–69

    CrossRefPubMedWeb of Science
25. ↵
    Moore A, Marecos E, Bogdanov A Jr, Weissleder R. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 2000;214:568–574

    CrossRefPubMedWeb of Science
26. Moore A, Marecos E, Simonova M, Weissleder R, Bogdanov A Jr. Novel gliosarcoma cell line expressing green fluorescent protein: a model for quantitative assessment of angiogenesis. Microvasc Res 1998;56:145–153

    CrossRefPubMed
27. Moore A, Weissleder R, Bogdanov A Jr. Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J Magn Reson Imaging 1997;7:1140–1145

    PubMedWeb of Science
28. ↵
    Fleige G, Nolte C, Synowitz M, Seeberger F, Kettenmann H, Zimmer C. Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 2001;3:489–499

    CrossRefPubMedWeb of Science
29. ↵
    Enochs WS, Harsh G, Hochberg F, Weissleder R. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 1999;9:228–232

    CrossRefPubMedWeb of Science
30. ↵
    Kleinschnitz C, Bendszus M, Frank M, Solymosi L, Toyka KV, Stoll G. In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging. J Cereb Blood Flow Metab 2003;23:1356–1361

    CrossRefPubMedWeb of Science
31. ↵
    Stoll G, Wesemeier C, Gold R, Solymosi L, Toyka KV, Bendszus M. In vivo monitoring of macrophage infiltration in experimental autoimmune neuritis by magnetic resonance imaging. J Neuroimmunol 2004;149:142–146

    CrossRefPubMed
32. ↵
    Shaw EG, Scheithauer BW, O’Fallon JR, Tazelaar HD, Davis DH. Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg 1992;76:428–434

    PubMedWeb of Science
33. Vonofakos D, Marcu H, Hacker H. Oligodendrogliomas: CT patterns with emphasis on features indicating malignancy. J Comput Assist Tomogr 1979;3:783–788

    PubMedWeb of Science
34. Daumas-Duport C, Tucker ML, Kolles H, et al. Oligodendrogliomas, II: a new grading system based on morphological and imaging criteria. J Neurooncol 1997;34:61–78

    CrossRefPubMed
35. Barker FG 2nd, Chang SM, Huhn SL, et al. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 1997;80:936–941

    CrossRefPubMed
36. ↵
    Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 2002;59:947–949

    Abstract/FREE Full Text